Sat.Nov 23, 2024 - Fri.Nov 29, 2024

article thumbnail

Delay and pay: Climate tipping point costs quadruple after waiting

Science Daily: Pharmacology News

The cost of reversing the effects of climate change -- restoring melted polar sea ice, for example -- quickly climbs nearly fourfold soon after a tipping point is crossed, according to new work. Much work has been done to explore the environmental costs tied to climate change. But this new study marks the first time researchers have quantified the costs of controlling tipping points before and after they unfold.

Research 138
article thumbnail

New data could help Merck expand use of cardiovascular drug

BioPharma Drive: Drug Pricing

Positive results from a study of Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent expirations this decade.

Drugs 117
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Diabetes Drug Metformin Might Help Fight Lung Cancer

Drugs.com

WEDNESDAY, Nov. 27, 2024 -- Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients have it as well, new research shows.Metformin appears to help boost the benefits of.

Drugs 109
article thumbnail

Cover Image

Chemical Biology and Drug Design

Cover Image © molekuul_be/Shutterstock.

100
100
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Unexplained heat-wave 'hotspots' are popping up across the globe

Science Daily: Pharmacology News

A striking new phenomenon is emerging: distinct regions are seeing repeated heat waves that are so extreme, they fall far beyond what any model of global warming can predict or explain. A new study provides the first worldwide map of such regions, which show up on every continent except Antarctica like giant, angry skin blotches.

127
127
article thumbnail

Alector turns to layoffs as Alzheimer’s drug fails

BioPharma Drive: Drug Pricing

The brain drug developer is letting go of around 41 of its 238 employees, in a move the company says will help “align resources” with its strategic priorities.

Drugs 109

More Trending

article thumbnail

Intellectual Property Rights and Regulatory Considerations for Drug Repurposing

Drug Patent Watch

In the ever-evolving landscape of pharmaceutical research and development, drug repurposing has emerged as a promising strategy to bring new treatments to patients more quickly and cost-effectively. However, navigating the complex web of intellectual property rights and regulatory considerations in this field can be challenging.

Drugs 95
article thumbnail

Nanorobot hand made of DNA grabs viruses for diagnostics and blocks cell entry

Science Daily: Pharmacology News

A tiny, four-fingered 'hand' folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them, researchers report. Dubbed the NanoGripper, the nanorobotic hand also could be programmed to interact with other viruses or to recognize cell surface markers for targeted drug delivery, such as for cancer treatment.

DNA 109
article thumbnail

Twelve Amazing Guest Blog Contributors!

addgene Blog

It’s a very thankful time of year for those of us at Addgene! And we can’t think of any better way to start off our holiday season than by thanking the twelve guest bloggers and subject matter experts who have contributed to our blog in 2024.

81
article thumbnail

Stroke Guidelines Updated, With Focus on Women and GLP-1s

Drugs.com

MONDAY, Nov. 25, 2024 -- Women, especially those who had high blood pressure during pregnancy or entered menopause before age 45, are among those with a greater risk for stroke.They and other high-risk groups are the focus of new stroke prevention.

106
106
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Unit Testing in Android Apps: A Deep Dive into MVVM

Perficient: Drug Development

Understanding Unit Testing Unit testing is a crucial aspect of software development, especially in complex applications like Android apps. It involves testing individual units of code, such as methods or classes, in isolation. This ensures the correctness of each component, leading to a more robust and reliable application. Why Unit Testing in MVVM?

80
article thumbnail

Clinical trial reveals twice-yearly injection to be 96% effective in HIV prevention

Science Daily: Pharmacology News

Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring HIV. This makes Lenacapavir significantly more effective than the standard daily oral PrEP (pre-exposure prophylaxis).

article thumbnail

How Intra-Cellular surprised Wall Street by breaking character

BioPharma Drive: Drug Pricing

The biotechnology company, which sees itself as "pretty conservative," recently put out an ambitious long-term revenue forecast for its schizophrenia and depression medicine Caplyta.

67
article thumbnail

Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds

Drugs.com

TUESDAY, Nov. 26, 2024 -- The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid.However, the move would have to be approved.

105
105
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Patient Centricity in Generic Drug Development: Best Practices

Drug Patent Watch

Patient centricity has become a crucial aspect of the pharmaceutical industry, particularly in the development of generic drugs. This approach focuses on understanding and addressing the needs and preferences of patients to ensure that the medications they receive are safe, effective, and easy to use.

article thumbnail

Uranus's swaying moons will help spacecraft seek out hidden oceans

Science Daily: Pharmacology News

A new computer model can be used to detect and measure interior oceans on the ice covered moons of Uranus. The model works by analyzing orbital wobbles that would be visible from a passing spacecraft. The research gives engineers and scientists a slide-rule to help them design NASA's upcoming Uranus Orbiter and Probe mission.

article thumbnail

Roche to buy cell therapy developer Poseida for $1B

BioPharma Drive: Drug Pricing

The deal suggests Roche sees substantial promise in Poseida’s technology, as the offer is 215% above the biotech’s closing share price on Monday.

article thumbnail

Could the Common Thyroid Medicine Levothyroxine Weaken Bones?

Drugs.com

MONDAY, Nov. 25, 2024 -- New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old age -- bone loss. Levothyroxine is a synthetic hormone often prescribed to treat hypothyroidism.

Research 102
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

How to Scale Up with Cohere: Insights from Aidan Gomez

BenchSci

Last month, we welcomed Aidan Gomez, CEO and Co-founder of Cohere, for our Scale Up series. As a leader in AI, Aidan co-authored the influential " Attention is All You Need " paper during his time at Google and has since co-founded Cohere , the leading data security-focused enterprise AI company. With the explosion of advancements in AI and its growing impact on industries worldwide, including drug discovery, our team was eager to hear Aidan’s unique technical perspective on building and scaling

Drugs 72
article thumbnail

Satellite evidence bolsters case that climate change caused mass elephant die-off

Science Daily: Pharmacology News

A new study has provided further evidence that the deaths of 350 African elephants in Botswana during 2020 were the result of drinking from water holes where toxic algae populations had exploded due to climate change.

109
109
article thumbnail

Biohaven muscle drug misses goal of SMA study, but advances in obesity

BioPharma Drive: Drug Pricing

The setback likely removes one competitor to an emerging spinal muscular atrophy medicine from Scholar Rock, but sets the stage for a pair of readouts with implications for weight loss research.

Drugs 67
article thumbnail

Scientists Develop Whole New Form of Effective Asthma Treatment

Drugs.com

THURSDAY, Nov. 28, 2024 -- Geoffrey Pointing says its hard to describe the distress of an asthma or COPD flare-up.“Honestly, when you're having a flare up, it's very difficult to tell anybody how you feel - you can hardly breathe,” Pointing, 77, of.

article thumbnail

The paradox of data in precision medicine

Drug Target Review

As the journey toward realising the full potential of precision medicine continues, one question frequently arises among pharma executives and biotech founders: why is progress so slow? A significant part of the answer may lie in the limitations of current technology in handling complex, multi-modal data – data that is crucial for advancing drug discovery and identifying new targets.

Science 59
article thumbnail

Astronomers may have discovered the answer to a mysterious stellar event

Science Daily: Pharmacology News

Researchers have made a record-breaking astrophysical discovery while simultaneously uncovering a possible explanation for the rare and extreme astrophysical event known as long-period radio transients.

Research 111
article thumbnail

Amgen obesity drug cuts weight in study, but results miss Wall Street’s high mark

BioPharma Drive: Drug Pricing

Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential rival to Wegovy and Zepbound.

Drugs 62
article thumbnail

Most Americans Don't Know Alcohol's Links to Cancer

Drugs.com

FRIDAY, Nov. 29, 2024 — Less than half of Americans realize that they're increasing their risk of cancer with every beer, cocktail or shot of whiskey.Despite public health warnings about the links between drinking and cancer risk, this widespread l.

95
article thumbnail

"Pink Cocaine", Otherwise Known As Tusi

Common Sense for Drug Policy Blog

"Pink Cocaine", Otherwise Known As Tusi "The tusi phenomenon complicates the drug landscape because it has the potential to confuse both people who use and researchers alike. With respect to people who use, given the drug concoction’s name, people may assume the drug is 2C/2C-B. Since many partiers are unfamiliar with 2C series drugs ( 14 ), there is also potential for people to simply think this is a new (and perhaps benign) drug – especially given that the powder is pink with a sweet scent.

article thumbnail

Simple secret to living a longer life

Science Daily: Pharmacology News

Increasing physical activity levels could extend your life up to 11 more years according to new research using accelometry data. The study found that for the least active people in the population, a single one-hour walk could return a benefit of six additional hours of life.

Research 108
article thumbnail

Kronos, Idorsia plan layoffs; PTC shelves ALS drug

BioPharma Drive: Drug Pricing

Kronos is cutting 83% of its workforce, while Idorsia is considering eliminating as many as 270 jobs. Elsewhere, PTC disclosed negative Phase 2 results for its ALS drug candidate utreloxastat.

Drugs 57
article thumbnail

Twice-Yearly Injection 96% Effective in Preventing HIV Infection

Drugs.com

THURSDAY, Nov. 28, 2024 -- People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themselves.But researchers have come up with a way to avoid that daily hassle – an injectable drug that patients.

article thumbnail

Biotech leader champions targeted cancer treatments and diversity

Drug Target Review

In the world of biopharmaceuticals, Dr Catherine Pickering stands out as a pioneering leader. As the CEO of iOnctura, an innovative oncology biopharmaceutical company she co-founded in 2017, Catherine has played a key role in advancing the development of highly targeted small molecules aimed at revolutionising cancer treatment. Her journey in drug R&D and business development has been marked by significant achievements, including leading groundbreaking efforts to treat neglected cancers and

article thumbnail

New study reveals the explosive secret of the squirting cucumber

Science Daily: Pharmacology News

A team has solved a mystery that has intrigued scientists for centuries: how does the squirting cucumber squirt? The findings were achieved through a combination of experiments, high-speed videography, image analysis, and advanced mathematical modelling.

107
107
article thumbnail

Sarepta rebuilds drug pipeline with Arrowhead deal

BioPharma Drive: Drug Pricing

A broad licensing and research alliance will hand Sarepta four clinical-stage candidates, while Arrowhead receives $500 million in cash and another $325 million in equity investment.